JPRN-UMIN000019397
未知
3 期
Pharmacogenomic study to predict warfarin stable dose in Japanese chidren. - Pharmacogenomic study to predict warfarin stable dose in Japanese chidren.
ational Center for Child Health and Development0 个研究点目标入组 480 人2015年11月1日
概览
- 阶段
- 3 期
- 干预措施
- 未指定
- 疾病 / 适应症
- congenital heart disease, Kawasaki disease, myocardiac disease, thromboembolism
- 发起方
- ational Center for Child Health and Development
- 入组人数
- 480
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •Patients whose warfarin dose has been changed within 28 days of the date of DNA sample collection Pregnant women and lactating women Patients who did not give written informed consent Patients who regularly (at least once/week) consume vitamin K\-rich foods and supplements such as natto, chlorella, green juice, and St. John's wort (Hypericum perforatum) Patients who are judged by the attending physician to be inappropriate as subjects for this study
结局指标
主要结局
未指定
相似试验
Unknown
4 期
Applying Pharmacogenetics to Warfarin Dosing in Chinese PatientsAtrial FibrillationDeep Vein ThrombosisPulmonary EmbolismHeart Valve DiseaseNCT01610141Chinese PLA General Hospital500
已完成
不适用
Genotype-guided Warfarin Individualized TreatmentAtrial FibrillationDeep Venous ThrombosisNCT02211326The Third Xiangya Hospital of Central South University660
已完成
不适用
Pharmacogenetics of Warfarin Induction and InhibitionHealthyNCT01447511University of Minnesota39
已完成
4 期
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic AlgorithmAtrial FibrillationPulmonary EmbolismDeep Vein ThrombosisNCT00511173Creighton University102
已完成
不适用
Genotype-Based Warfarin Therapy (GENWAT) studyAtrial fibrillationJPRN-UMIN000006794RIKE1,000